Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?

Aoki, Shuichi; Cobbold, Mark; Zhu, Andrew X; Duda, Dan G

Aoki, Shuichi; Cobbold, Mark; Zhu, Andrew X; Duda, Dan G.

Afiliação

Aoki S; Edwin L. Steele Laboratories, Department of Radiation Oncology.
Cobbold M; Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, MA.
Zhu AX; Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, MA.
Duda DG; Edwin L. Steele Laboratories, Department of Radiation Oncology.

Hepatology ; 67(3): 826-828, 2018 03.

Article em En | MEDLINE | ID: mdl-29077214

Assuntos

Carcinoma Hepatocelular; Nanomedicina; Sistemas de Liberação de Medicamentos; Humanos; Neoplasias Hepáticas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Nanomedicina Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google